← Back to Clinical Trials
Recruiting NCT05417334
Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum.
Trial Parameters
Condition Dyspareunia
Sponsor Hospital Clinic of Barcelona
Study Type INTERVENTIONAL
Phase N/A
Enrollment 110
Sex FEMALE
Min Age N/A
Max Age N/A
Start Date 2021-03-18
Completion 2025-12
Interventions
Resistive Capicitive Monopolar Radiofrequency
Brief Summary
This study evaluates if the application of resistive capacitive monopolar radiofrequency therapy associated with Thiele massage is effective when treating de novo dyspareunia at 4 to 9 months postpartum.
Eligibility Criteria
Inclusion Criteria: * 4-9 postpartum * de novo dyspareunia after delivery * obstetric injury * Grant informed consent Exclusion Criteria: * radiofrequency contraindications (pacemaker, active infection or pregnancy) * cesarean section * dyspareunia previous to labour * previous vulvo-vaginal pathology * patients with postpartum depression * patients with a pelvic region oncological history